Leo Pharma Eyes $800 Million Deal Push as IPO Plans Advance

Leo Pharma is moving forward with its IPO plans and is considering a deal worth $800 million. The company has a pharmaceutical manufacturing plant. Leo Pharma's advancements in IPO plans may lead to significant financial gains.